Justin Thomas Jordan MD ,MPH, FAAN
Neurooncology
Section Head for Neuro-Oncology, Section Head for Health Policy, Community Health, Global Neurology, Neurofibromatosis and Schwannomatosis Investigator, Associate Professor of Neurology and the O’Donnell Brain Institute, UT Southwestern Medical Center
Join to View Full Profile
5323 Harry Hines BlvdDallas, TX 75390
Dr. Jordan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an Associate Professor of Neurology with a secondary appointment in the O’Donnell Brain Institute at University of Texas Southwestern Medical Center in Dallas. I serve as the head of the Neuro-Oncology Section as well as the head of the Healthcare Policy, Community Health, and Global Neurology Section. I also run a large neurofibromatosis and schwannomatosis practice, incorporating clinical and translational research.
More broadly, I serve on multiple national and international committees, including vice-chair of the Advocacy Committee in the American Academy of Neurology (AAN), member of the Brain Health Committee in the AAN, and I represent the AAN to the European Academy of Neurology’s Brain Health Mission. I also sit on the board of Neurofibromatosis Network, and on the Clinical Care Advisory Board of the Children’s Tumor Foundation.
Education & Training
Harvard School of Public HealthMPH, Clinical Effectiveness, 2014 - 2016
Massachusetts General HospitalFellowship, Neuro-Oncology, 2013 - 2014
University of Texas Southwestern Medical CenterResidency, Neurology, 2009 - 2013
McGovern Medical School at UTHealthClass of 2009
Certifications & Licensure
NH State Medical License 2022 - 2026
TX State Medical License 2025 - 2026
MA State Medical License 2014 - 2025
PA State Medical License 2013 - 2014
American Board of Psychiatry and Neurology Neurology
United Council for Neurologic SubspecialtiesNeuro-Oncology Board Certification
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant Glioma.Gilbert Youssef, Elisa Aquilanti, Julie J Miller, Zhou Lan, Aleksandra B Lasica
Neuro-Oncology. 2025-12-15 - Multi-Institutional Assessment of Circulating Cell-Free DNA in Cerebrospinal Fluid Facilitates Central Nervous System Lymphoma Diagnosis and Treatment Initiation.Briana C Prager, Mihir Gupta, Timothy R West, Christopher M Ramundo, Jack Bagin
Neurosurgery. 2025-11-05 - 2 citationsIncreased Hemorrhage During Excision of Bevacizumab-Treated NF2-Related Vestibular Schwannomas.Christopher G Wood, Liana Kozanno, Anat Stemmer-Rachamimov, Daniel J Lee, Fred G Barker 2nd
The Laryngoscope. 2025-11-01
Journal Articles
- Increasing Access to Specialty Care for Rare Diseases: A Case Study Using a Foundation Sponsored Clinic Network for Patients with Neurofibromatosis 1, Neurofibromatosi...Scott R Plotkin, Justin T Jordan, BioMed Central
Press Mentions
Mask Mandates Expire in Beverly and LowellFebruary 4th, 2022
"The Future of Neurology Is Now"May 15th, 2019
Could the Burnout You’re Feeling Actually Be Compassion Fatigue?November 6th, 2018
Professional Memberships
- Member
- Society for Neuro-OncologyMember
- Children's Tumor FoundationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
